The occurrence of neuroleptic malignant syndrome in patients on antipsychotic therapy and factors influencing its development ...

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant ...

Paul E. Croarkin, DO, MS, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology, states: “Neuroleptic Malignant Syndrome is rare, serious, and previously understudied in ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to ...

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic ...

Yet, clinicians treating persons with autism continue to prescribe older neuroleptic agents targeting generic behavior problems -- despite the absence of psychosis and in the face of the serious ...

It has been recently suggested that these reports are an artifact, related to lessening of the impairment due to typical neuroleptic drugs and anticholinergic agents. The purpose of this study was ...